Metraipolis › archive › dc_4b8eb40545f7

RSV vaccine development: advances and fusion protein-focused strategies — Europe PMC PMID:41884825

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41884825
DOI
10.3389/fimmu.2026.1710895
License (as archived)
solo-consultazione
Archived
2026-11-05T12:15:43.878Z
SHA-256 of the archived text
7bd898697ec5bf047acdd7e80c5140f8a0e852b16c853f8e324c14903227f245
Stable URL of this page
https://metraipolis.com/documento/dc_4b8eb40545f7

How to cite

RSV vaccine development: advances and fusion protein-focused strategies — Europe PMC PMID:41884825 — Europe PMC (en), https://europepmc.org/article/MED/41884825 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4b8eb40545f7 (Metraipolis archive dc_4b8eb40545f7, sha256 7bd898697ec5bf047acdd7e80c5140f8a0e852b16c853f8e324c14903227f245)
BibTeX
@misc{dc4b8eb40545f7,
  title = {RSV vaccine development: advances and fusion protein-focused strategies — Europe PMC PMID:41884825},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41884825},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4b8eb40545f7; sha256 7bd898697ec5bf047acdd7e80c5140f8a0e852b16c853f8e324c14903227f245},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41884825. Agents can read the archived copy with the MCP tool read_document.